Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

NHS Foundation Trust signs collaboration agreement to automate laboratories

June 29, 2022 Research and Development

Automata has announced a commercial collaboration with University Hospital Southampton (UHS) NHS Foundation Trust, to accelerate automation within laboratories, enhance …
News

Polio virus detected in sewage from North and East London

June 22, 2022 Research and Development

Traces of the polio virus have been found during a routine sewage inspection in London. The UKHSA has consequently declared …
News

FDA grants Breakthrough Device Designation to pulmonary hypertension early detection AI

May 25, 2022 Research and Development

Anumana has announced the FDA had granted Breakthruogh Device Designation to its AI-enhanced ECG-based Pulmonary Hypertension (PH) Early Detection Algorithm. …
News

Clinical study of digital biomarker platform in degenerative neurological diseases

May 25, 2022 Research and Development

Cumulus Neuroscience has announced the start of two validation trials – CNS-101 and CNS-102 – supported by a group of …
News
mat-napo-pij34zrzeew-unsplash

WHO director warns ‘COVID-19 is not over’

May 25, 2022 Research and Development

Dr Tedros Adhanom Gebreyesus has delivered a message at the opening of the 75th World Health Assembly. He highlighted: “So, …
News

JCVI issues recommendations for booster jabs later this year

May 25, 2022 Research and Development

The JCVI has advised the government to provide an autumn COVID-19 booster programme in preparation for the winter. The recommendations …
News

NHS likely to miss its target on cancer, warns health chief

May 18, 2022 Research and Development

The NHS is likely to miss its target to return treatment waits for cancer to pre-COVID-19 levels by March 2023, …
News

Health secretary announces 10-year plan for dementia

May 18, 2022 Research and Development

Sajid Javid has announced plans to work across the government to boost the £375 million that is already committed for …
News

Study investigating VR treatment for chronic pain

May 18, 2022 Research and Development

AppliedVR and Kernel have partnered for a randomised study comparing the effect of AppliedVR’s FDA-authorised, VR-based program, RelieVRx, versus a …
News

More monkeypox cases detected in England

May 18, 2022 Research and Development

The UK Health Security Agency (UKHSA) says the risk presented by monkeypox to the public remains very low, though it …
News

SMC accepts chemotherapy-free VENCLYXTO for leukaemia treatment

May 11, 2022 Research and Development

The SMC has accepted venetoclax in combination with obinutuzumab, for use within NHS Scotland, as a first-line treatment for patients …
News

Europe’s first psychedelic drug trial clinic to open in London

May 11, 2022 Research and Development

British startup Clerkenwell Health aims to make the UK a global leader in psychedelic research and innovation, with Europe’s first …
News

Partnership researching genetics and treatments of long COVID

May 11, 2022 Research and Development

PrecisionLife Limited have announced a partnership with Sano Genetics, a genetic research platform enabling patients to participate in ethical research …
News

Ardena confirms spray drying upgrade and other capabilities at Spanish site

May 11, 2022 Research and Development

 
News

NIH launches clinical trial of vaccine for Epstein-Barr virus

May 9, 2022 Research and Development

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026